Your browser is no longer supported. Please, upgrade your browser.
Settings
HTBX Heat Biologics, Inc. daily Stock Chart
HTBX [NASD]
Heat Biologics, Inc.
Index- P/E- EPS (ttm)-0.51 Insider Own0.80% Shs Outstand34.08M Perf Week1.78%
Market Cap17.72M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float33.00M Perf Month-7.49%
Income-11.20M PEG- EPS next Q-0.10 Inst Own12.90% Short Float8.36% Perf Quarter-32.47%
Sales0.40M P/S44.30 EPS this Y71.80% Inst Trans8.01% Short Ratio8.93 Perf Half Y-44.68%
Book/sh0.45 P/B1.16 EPS next Y- ROA-115.10% Target Price3.00 Perf Year-27.78%
Cash/sh- P/C- EPS next 5Y- ROE-145.10% 52W Range0.46 - 3.35 Perf YTD-39.18%
Dividend- P/FCF- EPS past 5Y9.00% ROI-149.20% 52W High-84.48% Beta0.73
Dividend %- Quick Ratio7.70 Sales past 5Y12.70% Gross Margin- 52W Low12.55% ATR0.04
Employees19 Current Ratio7.70 Sales Q/Q- Oper. Margin- RSI (14)38.23 Volatility5.21% 8.30%
OptionableNo Debt/Eq0.00 EPS Q/Q76.30% Profit Margin- Rel Volume0.22 Prev Close0.52
ShortableYes LT Debt/Eq0.00 EarningsAug 14 BMO Payout- Avg Volume308.74K Price0.52
Recom2.00 SMA20-7.08% SMA50-16.08% SMA200-44.25% Volume69,239 Change0.17%
Jun-20-16Initiated ROTH Capital Buy
Jan-08-16Initiated Noble Financial Buy $16
May-26-15Initiated H.C. Wainwright Buy $13
Sep-18-13Initiated Aegis Capital Buy $36
Jul-03-17 12:15PM  Dr. Jeff Hutchins Appointed Chief Operating Officer for Heat Biologics Accesswire
09:21AM  Durham company considers stock split to avoid delisting American City Business Journals
07:05AM  Dr. Jeff Hutchins Appointed Chief Operating Officer for Heat Biologics Accesswire
07:00AM  Heat Biologics Appoints Damien Hallet as Vice President of CMC Development Accesswire
Jun-28-17 07:00AM  Pelican Therapeutics, a Subsidiary of Heat Biologics, Receives First Tranche of $15.2 Million CPRIT Grant Award Accesswire +24.44%
Jun-12-17 07:30AM  Heat Biologics to Present at the 2017 BIO International Convention Accesswire
Jun-07-17 07:00AM  Heat Biologics to Present at the 2017 Marcum Microcap Conference Accesswire
Jun-05-17 07:59AM  Heat Biologics Presents Poster on its Phase 2 Trial Evaluating HS-410 at ASCO Annual Meeting Accesswire
May-30-17 11:15AM  Heat Biologics to Present Poster at 2017 ASCO Annual Meeting Accesswire
May-11-17 05:55PM  Heat Bio pivots, will focus on combination therapies for cancer American City Business Journals
07:15AM  Heat Biologics Provides Business and Clinical Update for the First Quarter of 2017 Accesswire
May-02-17 10:50AM  Heat Bio completes acquisition of Texas company American City Business Journals
May-01-17 10:00AM  Heat Biologics Announces Completion of Acquisition of Pelican Therapeutics Accesswire
Apr-26-17 07:00AM  Heat Biologics to Present at PIONEERS 2017 Presented by Joseph Gunnar & Co. GlobeNewswire
Apr-12-17 06:18PM  OncoSec collaboration data 'promising' for embattled Heat Bio American City Business Journals
Apr-05-17 08:00AM  Heat Biologics Presents New Preclinical Data from OncoSec Collaboration at the American Association for Cancer Research (AACR) Annual Meeting GlobeNewswire
08:00AM  Heat Biologics Presents New Preclinical Data from OncoSec Collaboration at the American Association for Cancer Research (AACR) Annual Meeting
Mar-31-17 07:03AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
07:00AM  Heat Biologics Reports Fiscal Year 2016 Financial Results GlobeNewswire
Mar-28-17 04:01PM  Heat Biologics Closes Public Offering of 5,000,000 Shares of Common Stock GlobeNewswire
Mar-24-17 06:07AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statemen
Mar-23-17 01:35PM  2 Health Care Stocks Crushed on Thursday 24/7 Wall St. -15.83%
01:35PM  2 Health Care Stocks Crushed on Thursday
08:00AM  Heat Biologics Prices Offering of 5,000,000 Shares of Common Stock GlobeNewswire
07:50AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition
Mar-22-17 04:04PM  Heat Biologics Announces Proposed Public Offering of Common Stock GlobeNewswire
Mar-21-17 09:41AM  Heat Biologics Lung Cancer Drug Posts Good Results Investopedia +6.45%
09:41AM  Heat Biologics Lung Cancer Drug Posts Good Results at Investopedia
07:03AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  Heat Biologics Reports Positive Interim Phase 2 Lung Cancer Results in Patients Treated with HS-110 in Combination with a Checkpoint Inhibitor GlobeNewswire
Mar-20-17 07:00AM  Heat Biologics, Inc. to Present at The MicroCap Conference on April 4th in New York City Accesswire +5.68%
Mar-16-17 04:55PM  Heat Biologics faces threat of delisting again at bizjournals.com
07:02AM  Florida Department of Health Awards Three-Year Grant to Develop gp96-based Zika Vaccine GlobeNewswire
07:01AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standa
Mar-13-17 03:30PM  Heat Biologics Lung Cancer Drug Combo Succeeds at Investopedia +7.79%
07:03AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  Heat Biologics Meets Efficacy Endpoint in its Phase 1b Lung Cancer Trial to Progress to Phase 2 GlobeNewswire
Mar-09-17 09:35AM  Austin cancer-fighting startup to rejoin public company it spun out from in 2012 at bizjournals.com +9.23%
08:15AM  Blog Coverage Heat Biologics Acquires Controlling Stake in Immuno-Oncology Company Pelican Therapeutics Accesswire
08:00AM  Heat Biologics to Present at 29th Annual ROTH Conference GlobeNewswire
Mar-08-17 02:56PM  Durham outfit to acquire Texas company in a cash-stock deal at bizjournals.com
07:00AM  Heat Biologics Announces Agreement to Acquire Pelican Therapeutics GlobeNewswire
Mar-02-17 08:00AM  Heat Biologics to Present at the American Association for Cancer Research (AACR) Annual Meeting GlobeNewswire
Feb-21-17 03:01PM  Heat Biologics offers further bladder cancer treatment outlook at bizjournals.com
Feb-17-17 07:00AM  Heat Biologics Presents Immune Data on its HS-410 Phase 2 Bladder Cancer Trial at the Genitourinary Cancers Symposium GlobeNewswire
Feb-14-17 08:00AM  Heat Biologics to Present at the Genitourinary Cancers Symposium GlobeNewswire
Feb-03-17 06:05AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jan-27-17 12:17PM  These 5 Stocks Under $10 Could Get Hot Soon +14.89%
Jan-24-17 08:00AM  Heat Biologics to Present at NobleCon13 GlobeNewswire
Jan-17-17 11:08AM  Heat Biologics to reap benefit of new biotech at bizjournals.com
Jan-06-17 08:02AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +8.07%
Jan-05-17 08:00AM  Heat Biologics to Present at Biotech Showcase 2017 Conference in San Francisco GlobeNewswire
Jan-04-17 04:32PM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Defini
08:00AM  Heat Biologics Appoints Jeff Hutchins, Ph.D., as Chief Scientific Officer GlobeNewswire
Dec-09-16 04:01PM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement -5.59%
Dec-06-16 04:45PM  Heat Biologics stock active on heels of lung, bladder cancer results at bizjournals.com +8.11%
11:16AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:20AM  Heat Biologics Presents Topline HS-110/Nivolumab Combination Lung Cancer Results GlobeNewswire
Dec-01-16 10:38PM  Biotech Movers: Heat Biologics Inc (HTBX) And Achaogen Inc (AKAO) at Insider Monkey -64.11%
04:02PM  Rosen Law Firm Closes Investigation and Concludes There is No Basis for Securities Claims Against HTBX Business Wire
03:18PM  These Stocks Gained More Than 100% in November
02:18PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Heat Biologics, Inc. (HTBX) PR Newswire
01:14PM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Heat Biologics, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
11:52AM  INVESTOR LOSS ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Heat Biologics, Inc. - HTBX Business Wire
10:23AM  Heat Biologics Stock Falls on Negative Bladder Cancer Data
06:08AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Nov-30-16 05:28PM  Heat Biologics Presents Topline HS-410 Phase 2 Bladder Cancer Results at the Society of Urological Oncology Annual Meeting GlobeNewswire
Nov-28-16 03:30PM  Biotech Movers And Shakers: Heat Biologics Inc (HTBX) and Sunshine Heart Inc (SSH) at Insider Monkey +29.72%
08:25AM  Heat Biologics (HTBX) in Focus: Stock Moves 30.4% Higher
Nov-18-16 01:04PM  HEAT BIOLOGICS, INC. Financials
Nov-17-16 07:00AM  Heat Biologics to Present Topline HS-110/Nivolumab Combination Phase Ib Lung Cancer Results at the International Society for the Study of Lung Cancer Annual Meeting GlobeNewswire -5.90%
Nov-16-16 07:00AM  Heat Biologics to Present Topline HS-410 Phase II Bladder Cancer Results at the Society of Urological Oncology Annual Meeting GlobeNewswire
Nov-14-16 07:00AM  Heat Biologics Presents ComPACT Preclinical Data at the Society for Immunotherapy of Cancer Annual Meeting GlobeNewswire +9.02%
Nov-11-16 10:39AM  Heat Biologics losses decrease after cuts in R&D, workforce and salary deferrals at bizjournals.com
Nov-10-16 04:47PM  Heat Biologics Provides Corporate Update and Reports Third Quarter 2016 Financial Results GlobeNewswire
04:05PM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:05PM  HEAT BIOLOGICS, INC. Files SEC form 10-Q, Quarterly Report
Nov-07-16 07:00AM  Heat Biologics to Present at the Society for Immunotherapy of Cancer (SITC) Annual Meeting GlobeNewswire +6.16%
Oct-31-16 01:54PM  Heat Biologics CEO Interview Abuzz With Zika Developments: Collaboration, Vaccine And Other Initiatives
Oct-26-16 06:22PM  Durham-based Heat Biologics CEO talks new Zika collaboration at bizjournals.com +11.28%
Oct-25-16 07:00AM  Heat Biologics and University of Miami Announce Zika Vaccine Collaboration GlobeNewswire
Oct-17-16 07:30AM  Heat Biologics to Present at Two Upcoming Investor Conferences and Panel Discussion GlobeNewswire
Oct-13-16 07:00AM  Heat Biologics Remains on Track to Achieve Multiple Topline Data Readouts this Quarter GlobeNewswire -5.66%
Oct-11-16 07:30AM  Heat Biologics Selects Adaptive Biotechnologies to Discover Potential Clinical Biomarkers to Advance Novel Immunotherapies GlobeNewswire
Oct-07-16 07:00AM  Heat Biologics Substantially Reduces Debt and Reports Proceeds of Approximately $2.8 Million Year-to-Date from the Exercise of Warrants GlobeNewswire -6.77%
Oct-06-16 04:03PM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Sep-14-16 07:00AM  Heat Biologics Resumes Enrollment in its Non-Small Cell Lung Cancer Trial Evaluating HS-110 in Combination with Anti-PD-1 Checkpoint Inhibitor GlobeNewswire
Sep-13-16 01:38PM  3 Medical Stocks Under $10 to Buy Now
07:00AM  Heat Biologics to Present at Two Upcoming Investor Conferences GlobeNewswire
Aug-18-16 08:02AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Other Events
Aug-15-16 04:30PM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:21PM  HEAT BIOLOGICS, INC. Files SEC form 10-Q, Quarterly Report
04:15PM  Heat Biologics Provides Corporate Update and Reports Second Quarter 2016 Financial Results GlobeNewswire
Aug-08-16 02:17PM  Rising Oil, Strong Earnings Have Several Energy Stocks Jumping Today at Insider Monkey +38.17%
Jul-22-16 03:51PM  Heat Biologics Suspends Planned Public Offering -14.72%
08:10AM  Heat Biologics suspends proposed common stock public offering the day after announcing it at MarketWatch
08:00AM  Heat Biologics Announces Suspension of Proposed Public Offering of Common Stock GlobeNewswire
Jul-21-16 04:15PM  Heat Biologics Announces Proposed Public Offering of Common Stock GlobeNewswire -13.10%
04:01PM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Change in Directors or
Jul-07-16 07:00AM  Heat Biologics Announces Cancer Immunology Research Publication Featuring its ComPACT Platform Technology GlobeNewswire
Heat Biologics, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel allogeneic therapies for a range of cancers and infectious diseases in the United States. The company develops its products based on T cell-stimulating platform technologies, including immune pan-antigen cytotoxic therapy, a platform technology designed to educate and stimulate the immune system against specific disease targets, such as cancer cells; and combination pan-antigen cytotoxic therapy, a platform technology that combines a pan-antigen T cell activating vaccine and a T cell co-stimulator in a single product. Its product candidates include HS-110 that is in Phase 2 clinical trials for the treatment of non-small cell lung cancer; and HS-410, which is in Phase 2 clinical trials for the treatment of non-muscle invasive bladder cancer. The company was founded in 2008 and is based in Durham, North Carolina.